Marguglio David J. 4
4 · Adamis Pharmaceuticals Corp · Filed Nov 24, 2020
Insider Transaction Report
Form 4
Marguglio David J.
Director
Transactions
- Sale
Common Stock
2020-11-20$0.40/sh−35,000$14,000→ 287,264 total
Holdings
- 5,884(indirect: By Children)
Common Stock
Footnotes (2)
- [F1]The sales reported in this Form 4 were for the sole purpose of satisfying or paying income or withholding tax obligations of the undersigned.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.40 to $0.41, inclusive. The reporting person undertakes to provide Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.